EG17702A - Improvements in or relating to the synthesis of nizatidine - Google Patents

Improvements in or relating to the synthesis of nizatidine

Info

Publication number
EG17702A
EG17702A EG92/84A EG9284A EG17702A EG 17702 A EG17702 A EG 17702A EG 92/84 A EG92/84 A EG 92/84A EG 9284 A EG9284 A EG 9284A EG 17702 A EG17702 A EG 17702A
Authority
EG
Egypt
Prior art keywords
nizatidine
relating
synthesis
methyl
ylmethylthio
Prior art date
Application number
EG92/84A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23843341&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG17702(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of EG17702A publication Critical patent/EG17702A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Credit Cards Or The Like (AREA)
EG92/84A 1983-02-07 1984-02-07 Improvements in or relating to the synthesis of nizatidine EG17702A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46429683A 1983-02-07 1983-02-07

Publications (1)

Publication Number Publication Date
EG17702A true EG17702A (en) 1991-03-30

Family

ID=23843341

Family Applications (1)

Application Number Title Priority Date Filing Date
EG92/84A EG17702A (en) 1983-02-07 1984-02-07 Improvements in or relating to the synthesis of nizatidine

Country Status (27)

Country Link
EP (1) EP0116452B1 (cg-RX-API-DMAC7.html)
JP (1) JPS59152378A (cg-RX-API-DMAC7.html)
KR (1) KR860000767B1 (cg-RX-API-DMAC7.html)
AT (1) ATE84530T1 (cg-RX-API-DMAC7.html)
AU (1) AU559639B2 (cg-RX-API-DMAC7.html)
BG (1) BG45216A3 (cg-RX-API-DMAC7.html)
CA (1) CA1221369A (cg-RX-API-DMAC7.html)
CS (1) CS240994B2 (cg-RX-API-DMAC7.html)
DD (1) DD216459A5 (cg-RX-API-DMAC7.html)
DE (1) DE3486032T2 (cg-RX-API-DMAC7.html)
DK (2) DK164501C (cg-RX-API-DMAC7.html)
EG (1) EG17702A (cg-RX-API-DMAC7.html)
ES (1) ES8601941A1 (cg-RX-API-DMAC7.html)
FI (1) FI840474A7 (cg-RX-API-DMAC7.html)
GB (1) GB2134521B (cg-RX-API-DMAC7.html)
GR (1) GR81755B (cg-RX-API-DMAC7.html)
HU (2) HU194198B (cg-RX-API-DMAC7.html)
IE (1) IE56763B1 (cg-RX-API-DMAC7.html)
IL (1) IL70880A (cg-RX-API-DMAC7.html)
NZ (1) NZ207046A (cg-RX-API-DMAC7.html)
PH (1) PH19941A (cg-RX-API-DMAC7.html)
PL (1) PL138793B1 (cg-RX-API-DMAC7.html)
PT (1) PT78063A (cg-RX-API-DMAC7.html)
RO (1) RO87706A (cg-RX-API-DMAC7.html)
SU (1) SU1303028A3 (cg-RX-API-DMAC7.html)
UA (1) UA6020A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA84869B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80961A0 (en) * 1985-12-18 1987-03-31 Lilly Co Eli Synthesis of nizatidine
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Also Published As

Publication number Publication date
DD216459A5 (de) 1984-12-12
HU194198B (en) 1988-01-28
DK21292D0 (da) 1992-02-19
DE3486032T2 (de) 1993-05-19
HU190527B (en) 1986-09-29
FI840474L (fi) 1984-08-08
NZ207046A (en) 1986-06-11
DK51984A (da) 1984-08-08
EP0116452B1 (en) 1993-01-13
PL138793B1 (en) 1986-11-29
PL246097A1 (en) 1985-06-04
IE56763B1 (en) 1991-12-04
GB2134521A (en) 1984-08-15
JPH0576473B2 (cg-RX-API-DMAC7.html) 1993-10-22
PT78063A (en) 1984-03-01
DK164906B (da) 1992-09-07
EP0116452A3 (en) 1987-04-29
ES529492A0 (es) 1985-11-01
EP0116452A2 (en) 1984-08-22
GR81755B (cg-RX-API-DMAC7.html) 1984-12-12
RO87706B (ro) 1985-10-01
DK164501C (da) 1992-11-23
FI840474A7 (fi) 1984-08-08
AU2421584A (en) 1984-08-16
DK51984D0 (da) 1984-02-06
GB8403109D0 (en) 1984-03-07
PH19941A (en) 1986-08-14
CS81284A2 (en) 1985-06-13
DK164906C (da) 1993-01-25
SU1303028A3 (ru) 1987-04-07
KR840007591A (ko) 1984-12-08
IE840274L (en) 1984-08-07
BG45216A3 (bg) 1989-04-14
IL70880A0 (en) 1984-05-31
CS240994B2 (en) 1986-03-13
ATE84530T1 (de) 1993-01-15
FI840474A0 (fi) 1984-02-06
IL70880A (en) 1987-01-30
ZA84869B (en) 1985-09-25
KR860000767B1 (ko) 1986-06-23
ES8601941A1 (es) 1985-11-01
AU559639B2 (en) 1987-03-19
JPS59152378A (ja) 1984-08-31
DE3486032D1 (de) 1993-02-25
RO87706A (ro) 1985-10-31
CA1221369A (en) 1987-05-05
DK164501B (da) 1992-07-06
GB2134521B (en) 1986-10-01
UA6020A1 (uk) 1994-12-29
DK21292A (da) 1992-02-19

Similar Documents

Publication Publication Date Title
DE3175042D1 (en) 7-oxo-4-thia-1-aza(3,2,0)heptane and 7-oxo-4-thia-1-aza(3,2,0)hept-2-ene derivatives
EP0181001A3 (en) Polypeptide, a process for preparing the same, a pharmaceutical composition containing said polypeptide as well as the use thereof
GR3019814T3 (en) Process for producing intermediates for use in production of alkoxyiminoacetamides
DE3374865D1 (en) Process for preparing 4-hydroxy-2-methyl-n-2-pyridyl-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide
AU559639B2 (en) Synthesis of nizatidine
DE3171202D1 (en) Process for the preparation of cimetidine
DE3760618D1 (en) Synthesis of bicyclic aromatic sulfonyl chlorides
CA1273347C (cg-RX-API-DMAC7.html)
SE8104541L (sv) Sett att framstella 5-substituerade dialursyror
NZ212870A (en) A process for the preparation of 1,3-dihydro-4-pyridoyl-2h-imidazol-2-ones and intermediates therefor
GB2002350A (en) Preparation of tetramisole intermediate
GR3035263T3 (en) Process for preparing intermediates to nizatidine and related compounds.
SU1360131A1 (ru) Способ получения 2-трет-бутил-пероксиоксациклоалканов